“…prostate and oral cancer (Tu et al, 2016;Han et al, 2018b) Naringenin anti-proliferation CCND1, EREG, ESR2, MAPK1/14 cervical, colon, colorectal cancer, and hepatocarcinoma (Totta et al, 2004;Song et al, 2015;Zhang et al, 2016) Targets Cancer types Ref inhibiting metastasis AKT1, CDH1, MAPK1/4, MMP2/9, NCL, NFKB, PKCZ, PKCE, RAC1, RHO, RHOA, SCN9A, SNAIL1/2, TGFB1, TWIST1, VIM breast, lung, and bladder cancer (Liao et al, 2014;Zhang et al, 2016;Chang et al, 2017;Aktas and Akgun, 2018;Han et al, 2018c;Zhao et al, 2019b) promoting apoptosis AKT1, MAP3K5, ATF3, BAX, BCL2, BIRC5, CASP3/9, JNK, MAPK1/3/14, TP53, RPS6KB1, ROS1, RPS6…”